Latest news
Amylyx Maintained at Buy as Analyst Sees Strong Setup for LUCIDITY Trial; $34 Price Target Reaffirmed - TipRanksTipRanks · Sat, 08 Aug 2026 00:03:57 GMTJoseph Thome Reiterates Buy on Amylyx Ahead of Pivotal LUCIDITY Readout and $1.5B Peak Sales Opportunity for Avexitide - TipRanksTipRanks · Fri, 07 Aug 2026 09:37:06 GMTAmylyx Pharmaceuticals Readies for Pivotal LUCIDITY Data - TipRanksTipRanks · Fri, 07 Aug 2026 02:22:07 GMTAmylyx Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 15:04:22 GMTAMLX: LUCIDITY trial for avexitide nears topline data; cash runway extends into 2028 - TradingViewTradingView · Thu, 06 Aug 2026 11:03:57 GMTAmylyx Pharmaceuticals reports Q2 net loss $43.4M, cash $250.8M, runway into 2028 - TradingViewTradingView · Thu, 06 Aug 2026 11:03:01 GMTAmylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results - Business WireBusiness Wire · Thu, 06 Aug 2026 11:00:00 GMT